WO2001052014A2 - Systeme internet de depistage medical - Google Patents
Systeme internet de depistage medical Download PDFInfo
- Publication number
- WO2001052014A2 WO2001052014A2 PCT/US2000/031546 US0031546W WO0152014A2 WO 2001052014 A2 WO2001052014 A2 WO 2001052014A2 US 0031546 W US0031546 W US 0031546W WO 0152014 A2 WO0152014 A2 WO 0152014A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- user
- screen
- medical
- medical test
- tests
- Prior art date
Links
- 238000012216 screening Methods 0.000 title description 37
- 238000010339 medical test Methods 0.000 claims abstract description 44
- 230000004044 response Effects 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims description 55
- 230000000007 visual effect Effects 0.000 claims description 25
- 230000004304 visual acuity Effects 0.000 claims description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 208000002177 Cataract Diseases 0.000 claims description 6
- 206010030113 Oedema Diseases 0.000 claims description 5
- 206010013932 dyslexia Diseases 0.000 claims description 5
- 208000010412 Glaucoma Diseases 0.000 claims description 4
- 230000036648 cognitive speed Effects 0.000 claims description 4
- 230000001771 impaired effect Effects 0.000 claims description 4
- 208000013521 Visual disease Diseases 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 230000004297 night vision Effects 0.000 claims description 3
- 230000005043 peripheral vision Effects 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 2
- 208000035497 disorder of visual system Diseases 0.000 claims description 2
- 230000036997 mental performance Effects 0.000 claims description 2
- 230000009325 pulmonary function Effects 0.000 claims description 2
- 230000036387 respiratory rate Effects 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 130
- 230000003340 mental effect Effects 0.000 abstract description 3
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 8
- 238000007423 screening assay Methods 0.000 description 8
- 230000008859 change Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 208000001491 myopia Diseases 0.000 description 6
- 230000004379 myopia Effects 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000004456 color vision Effects 0.000 description 5
- 230000004305 hyperopia Effects 0.000 description 5
- 201000006318 hyperopia Diseases 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000002123 temporal effect Effects 0.000 description 5
- 206010020675 Hypermetropia Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000006992 Color Vision Defects Diseases 0.000 description 3
- 230000003935 attention Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 201000007254 color blindness Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000015654 memory Effects 0.000 description 3
- 230000002207 retinal effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000000418 atomic force spectrum Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000010370 hearing loss Effects 0.000 description 2
- 231100000888 hearing loss Toxicity 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 230000035987 intoxication Effects 0.000 description 2
- 231100000566 intoxication Toxicity 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 201000010041 presbyopia Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000001755 vocal effect Effects 0.000 description 2
- 230000003936 working memory Effects 0.000 description 2
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 241001183191 Sclerophthora macrospora Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003532 cataractogenesis Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 208000030251 communication disease Diseases 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000012074 hearing test Methods 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003923 mental ability Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000010332 selective attention Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
Definitions
- This invention relates generally to an Internet system and specifically to an Internet system which presents the user with a plurality of medical screening assays or tests which the end user can self administer.
- Web sites are relatively easy to create and such has resulted in a rapidly growing number of web sites.
- the growing number of web sites has resulted in intense competition between web site companies for business and among all web sites to attack traffic to the site.
- the value of a web site is measured by traffic or the number of "hits" the cite experiences per unit of time.
- the number of hits per unit of time has importance for at least two reasons. First, as more end users come to the web site the greater the likelihood that they will purchase goods. Second, the web site may generate all or a significant portion of its income from allowing others to advertise on the web site.
- the value of advertising in any media is related to the number of potential customers being reached.
- the internet has recently been increasing the efficiency of many industries.
- At the same time there have been efforts made to decrease the cost of providing medical services. This all is taking place at a time when people seem to have an increased interest in playing a role in and thereby improving the quality of their medical care.
- the present invention endeavors to improve the efficiency of providing medical services while allowing user patients to play a role in their own care via self-administered tests provided over the internet.
- a computer generated web site which allows end users to carry out medical screening assays or tests on themselves.
- the web site includes a plurality of symbols, icons or distinct areas which are each associated with a medical screening assay or test.
- the program initiates a screening assay or test corresponding to the symbol, icon or area on which the user "clicked. " More specifically, by clicking on an image of an eye the user is presented with one or more tests relating to the eye.
- the screening assays or tests are generally in one of three groups (1) users watch one or more symbols on a screen for some manner of change, e.g.
- the user responds to the change and is subsequently provided with information on the user, e.g. glucose level, peripheral vision, etc.; (2) users answer questions and the results are tabulated to provide the user with information on a specific characteristic of the user, e.g. adverse eating habits, probability of having or developing prostrate cancer, etc.; and (3) users react to a stimulus and/or question and the reaction and/or answer is measured against a standard to provide information to the user on criteria, e.g., cognitive ability, or degree of intoxication.
- criteria e.g., cognitive ability, or degree of intoxication.
- An aspect of the invention is a computer generated web site which allows users to access a plurality of medical screening assays or tests which can be self administered.
- An object of the invention is to provide a web site which will attract users.
- An advantage of the web site of the invention is that it provides users with a number of different medical screening assays and tests accessible at a single site.
- a feature of the web site is that its assays and tests can provide the user with useful medical information allowing the user to compare personal test results to known standards or to previous results.
- Another aspect of the invention is that it provides medical information to the user on subjects of specific interest to the user which information is relevant to test results provided to the user.
- Another feature of the invention is that it provides the user with an opportunity to purchase drugs, nutriceuticals, medical devices and medical books specific to the user's interest.
- the Internet provides an important tool for consolidating and presenting these "software only" diagnostic tests which require nothing more than a computer at the point-of-use.
- the present invention encompasses such and also covers medical tests which are facilitated by the Internet but require additional devices, e.g. ear phones or blood pressure gauge.
- URLs Uniform Resource Locators
- This reduces delay associated with accessing the screening test modules.
- this consolidation simplifies the process of tracking an individual's interest in specific tests as well as the appeal of a given test to multiple users.
- By tracking test utilization by users it is possible to market specific products and services to persons most likely to buy those products and services. For example, eye glasses to individuals exploring the site for vision-based testing or diabetes products to persons running the glucose-screening module.
- screening modules are by no means limited to executable code producing an animated graphics and sound.
- a screening module could represent a list of questions presented to the user. After the questions are answered, an interpretation in presented. For example, a list of questions designed to determine if the user is depressed, an alcoholic or suffering from benign prostatic hypertrophy.
- the site includes tests which are approved by the appropriate governmental agency (e.g. the FDA in the U.S.) and in a particularly preferred embodiment all of the tests are governmentally (e.g. FDA) approved tests.
- screening procedures could be implemented in a variety of ways including, running code remote to the server as well as, for example, Java applets which would be transparently downloaded by the user and run local to the user's computer.
- the web site used in the invention can be designed in any desired manner.
- the user is first presented with a screen briefly describing the web site, the types of tests provided and appropriate disclaimers.
- the initial screen may request user identification information and ask the user if the disclaimers have been read and understood.
- the user is provided access to a subsequent page.
- This page preferably obtains some basic information from the user such as age, sex, race, weight, height, current or prior medical condition including drugs currently used in treatment.
- the questions are preferably designed in a manner similar to that which would be completed by a patient on first visiting a caregiver, e.g. doctor, dentist, hospital, etc.
- the information obtained is stored in a server and used as needed for that particular user, e.g. to compare the users test results with other users with similar relevant characteristics.
- the user may be provided with an identification number. Such would allow the user to use a single test multiple times and/or use other tests without resending data.
- Systems of the type taught in U.S. Patent 5,960,411 issued September 28, 1999 are exemplary of this particular web site construction.
- the user is preferably provided access to a screen which shows a plurality of possible tests which the user may access and self administer.
- the different tests may be represented on the screen by any word, group of words, figure, or combination thereof.
- a test for color blindness may be represented by the phrase "color blindness test" alone or with colored lines, with or without an image of an eye.
- the symbols representing the tests may be randomly presented or presented in any desired order e.g. alphabetically, by class (e.g. medical or cognitive) or by the type of testing system used (e.g. question and answer or stimulus response).
- the tests available to users can be designed to provide very general information about the user or provide specific information about the condition of the user or a specific organ or system of the user.
- An important advantage of the invention is that there are large numbers of tests available for use which could provide valuable information to users if made readily accessible. However, it is generally too expensive to extensively commercialize any individual test. Thus, many potentially valuable tests remain both unknown and unused. By concentrating large numbers of tests together on a single web site, the expense of advertising can be diluted many times. Further, users of the tests provide further traffic to the web site by giving others the web site address when they are pleased with the results obtained or believe it might be of interest and/or value to others.
- the web site of the invention can be designed to include condensed versions of tests which are more fully available elsewhere.
- Tests provided on the web site of the invention are preferably designed such that no equipment or device beyond the user's screen and speakers are required. More preferably, the test can be carried out with only the user's screen, i.e. no need for speakers. However, it is understood that tests provided on the web site of the invention may be used with other devices or equipment. Simple examples of devices which may assist in carrying out other tests include all types of measuring devices e.g. a watch, an attachable probe, a thermometer, a scale, a flexible length measuring device, etc.
- earphones and eyeglasses could also be used to facilitate some vision and hearing tests of the invention.
- Another important advantage of the invention is that the web site will encourage subjects to screen multiple physical and/or physiological characteristics beyond those which may have originally attracted them to the site. For example, users coming to the site to test their vision might be surprised to find that a visual display can be used to determine glucose level in an individual. Users coming to the site to take a cognitive test might later return to the site to test their response time which could be related to the users blood alcohol level and as such the ability of the user to safely operate a motor vehicle.
- Medical tests included for use as part of the web site of the invention may be administered by the user, on the user, to provide information about the user - and is preferred thereby making the web site and its tests self contained, i.e. not requiring other people or devices.
- the tests on the web site of the invention might be carried out by one person on another, by one person on several others or by one person on one or more objects.
- the medical tests could greatly facilitate at home health care which could be carried out by the patient thereby reducing health care costs.
- a user/patient could self-administer a test, and the results could be sent and/or accessed electronically to a health professional.
- Tests could also be administered by teachers in schools to one or more students. Such tests would, for example, make it possible for teachers to quickly determine if a student had a learning disability.
- Medical tests could also be carried out by the user on an object, e.g. a body fluid.
- the user could be provided with a means to extract blood and an assay device to contact with the blood after which results created by the contact are provided back to a central location, an analysis carried out and results provided to a user.
- the main objective of the web site of the invention is not, necessarily, to sell goods.
- goods and advertising could be added.
- any medical test on the web site could be used to reference the user to a more complete version of the medical test which might be sold over the Internet.
- users found to have the characteristics of a certain disease could be referenced to a particular hospital, doctor or other healthcare organization or medical professional.
- Drugs, vitamins or nutriceuticals that could be used to treat or ameliorate a condition could be advertised to the user while meeting appropriate regulatory requirements.
- the tests on the web site of the invention could be readily used in a medical setting.
- the test may provide nothing more than a probability index as to whether the user had a particular disease or medical problem.
- tests with FDA approval could also be included thereby giving users a means of accurately screening themselves for various problems.
- medical costs could be dramatically reduced and the accessibility of medical care significantly expanded.
- the present invention may feature any number of sites that offer screening for physical and/or physiological visual acuity. Such sites may include, but are not limited to, screens for the following: visual acuity, e.g., U.S. Pat. Nos. 4,998,820 and 5,436,681; ability to distinguish colors, e.g., U.S. Pat No.
- dyslexia e.g., U.S. Pat. Nos. 4,706,686 and 5,420,653
- edema e.g., U.S. Pat Nos. 5,957,867 and 5,915,386
- pulmonary function e.g., U.S. Pat No. 4,296,756 and 4,796,639.
- Specific exemplary medical screening tests are briefly described below.
- a number of different tests can be used in the present invention to determine visual acuity, e.g., myopia (nearsightedness), hyperopia (farsightedness), presbyopia (age related inability to focus at near task), astigmatism and the like.
- Exemplary methods for computer- based screening of visual acuity include tests that screen for a single deviation (e.g., a screen only for myopia) and tests that screen for multiple tests simultaneously (e.g., hyperopia and myopia).
- U.S. Pat. No. 5,436,681 describes a method for simultaneously screening myopia and hyperopia.
- This patent provides a vision screening apparatus and screening method that includes a myopic screening test image and a hyperopic screening test image.
- Each screening test image includes a test letter member superimposed on a colored background member that, in combination, forms the myopic screening test image portion and the hyperopic screening test image portion.
- the myopic test image is formed by a test image member, such as a letter, superimposed on a red colored background.
- the hyperopic screening test image is formed by a test image, such as a letter, superimposed on a green colored background.
- the method includes determining the patient's visual acuity of the displayed myopic and hyperopic test images, and then determining which, if any, of the conditions exists.
- Good visual acuity of the myopic test image indicates myopia in an individual, while good visual acuity of the hyperopic test image indicates hyperopia.
- Good visual acuity of both test images indicates no condition.
- Use of the apparatus at less than one meter distance results in a method of screening for an inability to focus on a near task (presbyopia).
- U.S. Pat. No. 4,998,820 provides an optical instrument for use in conducting optometric examinations which generates an alphanumeric type display simulating the optical features of displays provided by video display terminals.
- the computer screen generates characters which are comprised of pixel-like light elements.
- the computer screen can degrade the image quality of the characters by transforming the light elements into Gaussian type spatial profiles typical of the pixels generated by VDTs, thus further testing the ability of an individual to distinguish the form of letters and/or numbers.
- Color Vision Screening The present invention can also can include methods for screening color blind individuals. These tests may optionally screen for visual acuity simultaneously.
- U.S. Pat No. 5,801,809 provides a method for testing color perception at the same time that visual acuity is measured.
- the computer generated eye chart with color vision screening includes a chart which displays objects of progressively smaller sizes with the larger sized objects being displayed in color to measure color perception. The smaller objects are displayed black on the white background to provide a measurement of visual acuity.
- Scotopic sensitivity syndrome (commonly referred to as being "night blind”) can be initially screened using computer generated visuals.
- U.S. Pat. No. 5,067,806 describes a method for determining using a visual pattern and the presence or absence of a colored filter. The filters are chosen to reflect the spectral sensitivity of the cones and their combinations. Two different filtered images with the same test patterns are shown to the subject, and the subject determines which is clearer. The image chosen is kept and compared to a next figure with a different filter, and so forth. The last figure always given is the one without a filter. The patient is then asked if the filtered image is clearer than the unfiltered. The patient who sees a filtered image better than the unfiltered is referred for further testing by an optometrist familiar with this syndrome. If the unfiltered image is clearer the patient does not have scotopic sensitivity syndrome.
- U.S. Pat. No. 5,713,353 provides a visual method for determining blood glucose levels by providing a changing light pattern which changes in regard to one or several parameters defining its luminance, color, rate of flicker, spatial contrast, detail content, speed or otherwise provided that the change gradually stimulates one retinal system more than another retinal system.
- the subjective visual effect indicates a specific ratio of stimulation of the two retinal systems, for example the point of balanced stimulation of the two systems.
- the patient actuates a mechanism which takes note of the current light pattern parameter values, allowing the device to relate such parameter values with a corresponding blood glucose level using predetermined calibration data.
- U.S. Pat. Nos. 5,946,075 and 5,061,059 provide a method for detecting the presence of glaucoma and diabetes-associated eye disease in a human eye.
- a test subject is presented with a fixation target positioned on a computer screen The test subject focuses a test eye on the fixation target and positions the test eye a sufficient separation distance from the fixation target and aligns the test eye relative to said fixation target so that the test subject's central and peripheral visual health can be tested. Additional marks are presented on the computer screen for detection by the test subject using the peripheral vision of the test eye.
- the additional marks are primarily the same level of black-white contrast as the computer screen but different in hue to create color contrast symbols, and are presented within the field of vision of an eye not afflicted with the disease for which testing is being conducted. The potential presence of eye disease is detected if the additional marks are not visible to the test subject.
- each light comprises a mixture of two different wavelength lights (e.g., different colored lights).
- One of the lights is a fixed reference mixture, while the mixture of the other light is varied until the patient observes a match between the two lights in terms of hue, brightness and saturation.
- the luminance levels of the test light wavelength components for providing the match and the proportionate levels of the standard and test light components are then determined.
- the shorter wavelength light of the test light mixture is substituted with a new wavelength light and the new mixture varied again until the patient observes a match as before.
- the luminance levels of the light components of the new test light are then determined and another proportion obtained representative of the proportionate levels thereof.
- the first and second proportions are then compared to respective proportions of a standardized group. Deviations between the proportions of the patient and the standardized group indicate the existence of a cataract and/or the degree of a cataract precursor formation.
- Reaction time can be determined based on eye-hand response reaction to visual cues.
- U.S. Pat. No. 5,079,726 provides determination of response speed and accuracy measurement by providing a multidigit code generator for generating a multidigit code of numeric or alphabetic characters or other symbols.
- An operator controlled start switch causes a code to be generated and displayed for a limited fixed time duration. The operator then attempts to enter the last displayed code as quickly as possible using the data entry keys of a keyboard.
- a timer measures the operators response time. The entered code is compared against the displayed code for detecting a match. An output is generated in the event of a match to indicate the operator's response time.
- 5,919,046 provides a hazard perception test system comprising a CRT screen for displaying a sequence of images of a scene to be viewed by a test subject and in which at least one hazard appears, the images establishing a state of relative movement between at least one hazard and the test subject, a computer for generating a select signal in response to an action by the subject, the select signal representing an image in the sequence selected by the subject as a point in the sequence at which to change the state, and for determining the ability of the subject to satisfactorily perceive hazards on the basis of the select signal.
- U.S. Pat. No. 5,888,074 provides a system for testing and evaluating driver situational awareness using a display of road and traffic images.
- Road and traffic image data for simulating operation of a vehicle are generated on a display device, and instruction data provided. Response time is measured by measuring user input in response to road and traffic image data generated on the display means.
- the control device incorporates a vision test component for conducting a vision test of the subject and a driving reaction test component for conducting a driving reaction test of the subject.
- the test pattern image data is structured to test static visual acuity, static visual contrast sensitivity, dynamic visual acuity, dynamic visual contrast sensitivity and angular motion sensitivity.
- the situation test image data is structured to test divided attention capacity, selective attention capacity, attention switching, working memory functions, brake reaction time, and complex reaction time and decision making.
- U.S. 4,706,686 provides a method for identifying individuals that are possibly suffering from dysmetric dyslexia by providing a visual display consisting of a plurality of discrete objects moving in a continuous line between a pair of spaced stationary objects. The subject reads the display from a distance at which normal subjects being screened are capable of seeing not only the moving objects but both stationary objects within their field of vision. Those failing to see the entire display are identified as possibly being dyslexic.
- U.S. Pat. No. 5,420,653 provides a quantitative visual test to measure the rate at which an individual is able to complete a defined visual task.
- the task involves comparing a plurality of similar appearing numbers to determine if they are an exact match within predetermined levels of time. Inability to complete the test within the predetermined level of time indicates the likelihood that the individual will exhibit visual stress and dyslexia. Hearing Loss
- Hearing loss may be tested using a system with the ability to produce sound, e.g. through the use of a sound card and speaker system associated with a computer.
- U.S. Pat Nos. 5,119,826 provides a method for screening hearing by providing a series of natural sound stimuli, which are controlled in intensity and spectrum, in various frequency bands and recording. The user responds to these stimuli and the response is recorded within a time interval after each stimulus. The intensity and spectrum of the subsequent sound stimuli in the same or in another frequency band are determined on the basis of the result of each response test. The sound stimuli mentioned are based on processed sound signals derived from the environment.
- U.S. Pat. No. 5,230,629 describes a cognitive speedometer for the assessment of cognitive processing speed that includes a display screen, a keyboard, and a processor for generating original data and displaying on the screen the original data for copying by a user on the keyboard.
- Original data is displayed to a user, and if the user copies the displayed original data correctly, the processor generates and displays on the screen different data on which the user is to perform a unit cognitive operation and then enter the resultant data on the keyboard. The processor then determines the time required for the user to perform the unit cognitive operation.
- U.S. Pat. No. 5,017,142 provides an interactive method for testing the working memory of a test subject.
- the method includes displaying several encoded symbols randomly positioned on a video display for a predetermined period of time, with the position of each encoded symbol corresponding to specific coordinates on a video display.
- Each symbol has a predetermined priority that must be determined by a test subject based on recognized variables associated with each symbol.
- the symbols are deleted from the video display after expiration of the predetermined period.
- a second set of symbols are displayed on the video display in the same pattern as were the first symbols so that there is a cardinal relationship between the coordinates of the second symbols and those of the first symbols.
- Each first and second symbol having identical coordinates forms a symbol pair.
- the test subject's task is to assign a priority to the second symbols based on the test subject's recollection of the priority of each first symbol.
- the program implementing the test compares the assigned priorities of the second symbols to the actual priority of the first symbols and provides an output which is the sum of the number of correct priority assignments.
- U.S. Pat. No. 5,91 1,581 describes an interactive system for measuring and training of mental ability.
- the computer-based method automatically presents a variety of visual and auditory stimuli.
- the system measures reaction to the stimuli, adjusts certain stimulus parameters, and provides scores in response to an individual's reactions.
- the scores are tabulated and displayed for analysis.
- the screen monitors physical reaction time, perceptual awareness thresholds, attention level, speed, efficiency and capacity of information processing by the brain and elementary cognitive processes, including memory, memory access and decision-making speed.
- the invention measures, identifies and quantifies noise in the subject's brain and elementary cognitive processing system, and the information exchange rate between the subject's left and right brain hemispheres.
- the complexity of the tests can be adjusted based on the scores to optimally challenge cognitive capacities, thereby providing more accurate evaluations of cognitive capacity, and optimizing learning of desired improvements in perceptual, physical and mental response speeds and efficiencies.
- U.S. Pat. No. 5,813,862 provides a screen that enables individuals with speech, language and reading based communication disabilities, due to a temporal processing problem, to monitor and improve their temporal processing abilities.
- the methods includes method means to modify fluent speech to make the modified speech better recognizable by communicatively impaired individuals.
- the screen provides mechanisms for detecting improvements in temporal processing abilities, specifically speed and precision of temporal integration, sequencing and serial memory.
- U.S. Pat. No. 5,302,132 provides a method for evaluating literacy of an individual and reducing illiteracy of individuals accompanied by improvements in functionality utilizing computer technology to integrate multi-sensory stimuli for synthesis of individualized instruction, evaluation, and prescription for advancement of communications skills.
- Medical conditions can be monitored and recorded using a screening method that employs a device associated with a computer system, e.g., a probe that is simultaneously attached to a subject and to a computer system and which transduces information from the subject to the computer system.
- a device associated with a computer system e.g., a probe that is simultaneously attached to a subject and to a computer system and which transduces information from the subject to the computer system.
- U.S. Pat. Nos. 5,957,867 and 5,915,386 provide methods and devices for detecting the presence of edema in a subject.
- the methods utilize a probe extending from the computer system and contacted with the surface of the extremity to be tested.
- the probe is contacted to form a depression in the skin surface of the extremity, and held in constant position for a period of time during which a plurality of force measurements and a force profile is generated.
- the force profile is then related to the presence of edema in the patient.
- These screens can
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001229051A AU2001229051A1 (en) | 2000-01-11 | 2000-11-17 | Medical internet screening system |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17548400P | 2000-01-11 | 2000-01-11 | |
US60/175,484 | 2000-01-11 | ||
US59693900A | 2000-06-19 | 2000-06-19 | |
US09/596,939 | 2000-06-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001052014A2 true WO2001052014A2 (fr) | 2001-07-19 |
WO2001052014A3 WO2001052014A3 (fr) | 2002-01-17 |
Family
ID=26871257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/031546 WO2001052014A2 (fr) | 2000-01-11 | 2000-11-17 | Systeme internet de depistage medical |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001229051A1 (fr) |
WO (1) | WO2001052014A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003015629A1 (fr) * | 2001-08-20 | 2003-02-27 | Inverness Medical Limited | Dispositifs sans fil pour la gestion du diabete et procedes d'utilisation associes |
EP1559364A1 (fr) * | 2001-08-20 | 2005-08-03 | Inverness Medical Limited | Dispositifs sans fil pour la gestion du diabète et procédés d'utilisation associés |
WO2011084853A1 (fr) * | 2010-01-07 | 2011-07-14 | Lisa Halff | Système et procédé réactifs à un événement détecté au niveau d'un dispositif de surveillance du glucose |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6186145B1 (en) * | 1994-05-23 | 2001-02-13 | Health Hero Network, Inc. | Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator |
US6206829B1 (en) * | 1996-07-12 | 2001-03-27 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including network access |
US5954640A (en) * | 1996-06-27 | 1999-09-21 | Szabo; Andrew J. | Nutritional optimization method |
US6045515A (en) * | 1997-04-07 | 2000-04-04 | Lawton; Teri A. | Methods and apparatus for diagnosing and remediating reading disorders |
-
2000
- 2000-11-17 WO PCT/US2000/031546 patent/WO2001052014A2/fr active Application Filing
- 2000-11-17 AU AU2001229051A patent/AU2001229051A1/en not_active Abandoned
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003015629A1 (fr) * | 2001-08-20 | 2003-02-27 | Inverness Medical Limited | Dispositifs sans fil pour la gestion du diabete et procedes d'utilisation associes |
EP1559364A1 (fr) * | 2001-08-20 | 2005-08-03 | Inverness Medical Limited | Dispositifs sans fil pour la gestion du diabète et procédés d'utilisation associés |
CN1311781C (zh) * | 2001-08-20 | 2007-04-25 | 因弗内斯医疗有限公司 | 无线糖尿病管理装置及使用该装置的方法 |
WO2011084853A1 (fr) * | 2010-01-07 | 2011-07-14 | Lisa Halff | Système et procédé réactifs à un événement détecté au niveau d'un dispositif de surveillance du glucose |
US8803688B2 (en) | 2010-01-07 | 2014-08-12 | Lisa Halff | System and method responsive to an event detected at a glucose monitoring device |
Also Published As
Publication number | Publication date |
---|---|
WO2001052014A3 (fr) | 2002-01-17 |
AU2001229051A1 (en) | 2001-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018232920B2 (en) | Systems and methods to assess cognitive function | |
JP4786119B2 (ja) | 検眼システム、検眼装置、及びそのプログラム及び記録媒体、並びに、標準化方法 | |
Massof et al. | Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision | |
Deruaz et al. | Reading with multiple preferred retinal loci: implications for training a more efficient reading strategy | |
Bertone et al. | The impact of blurred vision on cognitive assessment | |
Jordan et al. | Reading with a filtered fovea: The influence of visual quality at the point of fixation during reading | |
Strickland-Hughes et al. | Own-age bias in face-name associations: Evidence from memory and visual attention in younger and older adults | |
Spear et al. | Qualitative differences in manifest object representations: Implications for a multidimensional model of psychological functioning. | |
Warrian et al. | Performance-based measures of visual function | |
Addleman et al. | Simulated central vision loss does not impair implicit location probability learning when participants search through simple displays | |
Enoch et al. | Development of clinical tests of vision: Initial data on two hyperacuity paradigms | |
WO2001052014A2 (fr) | Systeme internet de depistage medical | |
Hunt et al. | Near-vision acuity levels and performance on neuropsychological assessments used in occupational therapy | |
Kammer | Performance of an augmented reality device on functional activities of low vision patients with age related macular degeneration | |
JP2001344339A (ja) | 薬剤学的認知障害の測定 | |
Ünver et al. | Interactive, computer-based, self-reported, visual function questionnaire: the PalmPilot-VFQ | |
Siddiqui et al. | Visual contrast functions in children with severe visual impairment and the relation to functional ability | |
Pizzimenti et al. | The low vision rehabilitation service. Part two: Putting the program into practice | |
Whittaker et al. | Occupational Therapy Low Vision Rehabilitation Evaluation | |
Selvan | The Development of Patient-Reported Outcome Measures and an Observer-Reported Outcome Measure for Pediatric Patients with Inherited Retinal Disease | |
Tripathi et al. | An updated approach to low-vision assessment | |
Courtney-Harris | The evaluation of a vision screening tool for the detection of vision problems in stroke survivors | |
Mwangi | Techniques to Support Early Identification of Children with Vision Problems in Public Primary Schools in Central Kenya | |
Hall | Functional visual fields: Norms for younger and older viewers | |
Ferrell et al. | A Meta-analysis of Educational Applications of Low Vision Research: Technical Report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |